These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11083774

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine's Refinement and Evolution.
    Turbyfill KR, Clarkson KA, Oaks EV, Kaminski RW.
    Vaccines (Basel); 2022 Apr 01; 10(4):. PubMed ID: 35455297
    [Abstract] [Full Text] [Related]

  • 25. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.
    Simon JK, Maciel M, Weld ED, Wahid R, Pasetti MF, Picking WL, Kotloff KL, Levine MM, Sztein MB.
    Clin Immunol; 2011 May 01; 139(2):185-92. PubMed ID: 21388888
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.
    van de Verg LL, Mallett CP, Collins HH, Larsen T, Hammack C, Hale TL.
    Infect Immun; 1995 May 01; 63(5):1947-54. PubMed ID: 7729907
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS, Kaur G, Sivaramakrishna U, Singh D, Bansal A.
    Vaccine; 2016 Oct 17; 34(44):5376-5383. PubMed ID: 27591952
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
    Lu T, Das S, Howlader DR, Jain A, Hu G, Dietz ZK, Zheng Q, Ratnakaram SSK, Whittier SK, Varisco DJ, Ernst RK, Picking WD, Picking WL.
    Front Immunol; 2023 Oct 17; 14():1194912. PubMed ID: 37744341
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC, Wu T, Grassel CL, Shimanovich A, Pasetti MF, Levine MM, Barry EM.
    Pathog Dis; 2016 Jul 17; 74(5):. PubMed ID: 27106253
    [Abstract] [Full Text] [Related]

  • 36. Characterization of Functional B-Cell Epitopes at the Amino Terminus of Shigella Invasion Plasmid Antigen B (IpaB).
    Li S, Han X, Upadhyay I, Zhang W.
    Appl Environ Microbiol; 2022 Aug 09; 88(15):e0038422. PubMed ID: 35856689
    [Abstract] [Full Text] [Related]

  • 37. Functional analysis of the Shigella flexneri IpaC invasin by insertional mutagenesis.
    Bârzu S, Benjelloun-Touimi Z, Phalipon A, Sansonetti P, Parsot C.
    Infect Immun; 1997 May 09; 65(5):1599-605. PubMed ID: 9125536
    [Abstract] [Full Text] [Related]

  • 38. The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD.
    Ménard R, Sansonetti P, Parsot C.
    EMBO J; 1994 Nov 15; 13(22):5293-302. PubMed ID: 7957095
    [Abstract] [Full Text] [Related]

  • 39. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec 15; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.